Cytrellis Biosystems Completes $50 Million Series C Financing

Investment Led by D1 Capital Partners Will Support the Company's Commercialization Efforts and R&D Investments WOBURN, Mass., Sept. 21, 2021 -- (Healthcare Sales & Marketing Network) -- Cytrellis, a medical technology company dedicated to the developme... Devices, Dermatology, Venture Capital Cytrellis Biosystems, ellacor System, Micro-Coring
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news